Back to results
US 11,538,580 B2Granted
Method and system for providing basal profile modification in analyte monitoring and management systems
AssigneeAbbott Diabetes Care Inc.
InventorsMark Kent Sloan, Gary Alan Hayter
Life of this patent
Estimating the term…
Abstract
Method and system for providing basal profile modification in insulin therapy for use with infusion devices includes periodically monitoring the analyte levels of a patient for a predetermined period of time in order to determine, based on the monitored analyte levels, an appropriate modification factor to be incorporated into the underlying basal profile which was running at the time the periodic monitoring of the analyte levels were performed.
Claims22
A method, comprising:
- retrieving a current drug therapy profile of a user;
- monitoring, using a continuous in vivo analyte monitoring unit, a continuous, in vivo analyte level of the user for a predetermined period of time during which a medication is administered to the user according to the current drug therapy profile;
- retrieving a predetermined parameter, wherein the predetermined parameter comprises an iterative loop gain factor;
- determining a modification to the current drug therapy profile based on the monitored analyte level and the predetermined parameter during the predetermined period of time;
- and
- adjusting a drug dosage or rate for administration by a drug delivery device based at least on the modification to the current drug therapy profile.
3 more elements
A system, comprising:
- a continuous, in vivo analyte monitoring unit;
- and
- a processing unit operatively coupled to the in vivo analyte monitoring unit, the processing unit configured to:
- retrieve a current drug therapy profile of a user:
- receive a plurality of monitored analyte levels of the user for a predetermined period of time during which a medication is administered to the user according to the current drug therapy profile;
- retrieve a predetermined parameter, wherein the predetermined parameter comprises an iterative loop gain factor;
- determine a modification to the current drug therapy profile based on the received plurality of monitored analyte levels and the predetermined parameter during the predetermined period of time;
- and
- adjust a drug dosage or rate for administration by a drug delivery device based at least on the modification to the current drug therapy profile.
6 more elements
A system, comprising:
- a continuous, in vivo glucose monitoring unit;
- and
- a processing unit operatively coupled to the in vivo glucose monitoring unit, the processing unit configured to:
- retrieve a current insulin therapy profile of a user;
- receive a plurality of monitored glucose levels of the user for a predetermined period of time during which insulin is administered to the user according to the current insulin therapy profile;
- retrieve a predetermined parameter, wherein the predetermined parameter comprises an iterative loop gain factor;
- determine a modification to the current insulin therapy profile based on the received plurality of monitored glucose levels and the predetermined parameter during the predetermined period of time;
- and
- recommend the modification to the current insulin therapy profile to the user;
- and
- an insulin delivery device unit configured to treat the user based on at least the modification to the current drug therapy profile, wherein treating the user comprises administering and/or adjusting based at least on the modification to the current drug therapy profile:
- an insulin dosage, an insulin rate, or any combination thereof.
9 more elements
Dependencies are inferred from the claim text.